Investigation of the compliance of medicinal provisions with the disease structure of patients receiving pharmacotherapy under the Program for Providing Certain Categories of Citizens with Necessary Medicine

The most important component of the rational use of medicines in the preferential medicinal segment is the purchase of medicines based on patient nosological analysis.

Objective. To investigate the compliance of medicinal provision with the structure of diseases of patients receiving pharmacotherapy under the Program for providing certain categories of citizens with necessary medicines (Program) and develop recommendations for improvement.

Materials and methods. A nosological analysis of 463 forms of medical and social expertise in 125,234 patients, an ABC/VEN-analysis of the nomenclature of medicines purchased for the Program over a 3-year period, and an assessment of rational medicinal use using descriptive statistics methods were carried out.

Results. A significant discrepancy was observed between the number of patients in the disease groups and the volume of funding for medicines. Less money is spent on purchasing medicines for the treatment of diseases that occupy leading positions in terms of the number of patients, — cardiovascular diseases and malignant neoplasms, than on medicines for the treatment of other diseases that affect a smaller number of patients.

Conclusions. There is a discrepancy between the medicinal supply and the structure of patients’ diseases, which is due to irrational planning of the range of purchased medicines, and requires correction.

1. Strategy for the development of the pharmaceutical industry of the Russian Federation for the period up to 2030: Order of the Government of the Russian Federation dated Order of the Government of the Russian Federation dated June 7, 2023 No. 1495 (In Russ.)]. Доступно по: https://clck.ru/3DkYdy. Ссылка активна на 30.09.2024.

2. Telnova EA. Experiment ahead of time: about the Moscow experiment on preferential drug provision. Remedium. 2019;(10): 70-75. (In Russ.)]. doi: 10.21518/1561-5936-2019-10-70-75.

3. Telnova EA, Plesovskikh AV. About the drug provision of the population – from vexed problems to effective solutions. Vestnik Roszdravnadzora. 2019;(6):74-81. (In Russ.)]. doi: 10.35576/2070-7940-2019-2019-6-74-81.

4. Vovk EG, Yagudina RI, Serpik VG, Gavrilina NI. Monitoring the implementation of preferential drug provision in the subjects of the Russian Federation in the period from 2017 to 2022. Vestnik Roszdravnadzora. 2023;(4):80-83. (In Russ.)]. EDN: LFOAJO.

5. Linnik SA, Shvachko SA, Tumenko EE. Subsidized Pharmaceutical Provision for patients in the Federal Districts and subjects of the Russian Federation using the example of the most common diseases. Manager Zdravoohranenia. 2023;(2):40-49. (In Russ.)]. doi: 10.21045/1811-0185-2023-2-40-49.

6. Petrukhina IK, Yagudina RI, Ryazanova TK, et al. Analysis of the implementation of the federal assurance program of supporting beneficiaries with indispensable medicinal preparations in the subjects of the Russian Federation. Pharmacy & Pharmacology. 2020;8(4):273-284. (In Russ.)]. doi: 10.19163/2307-9266-2020-8-4-273-284.

7. Samoilova AV, Vovk EG, Yagudina RI, et al. Analysis of data monitoring provision of necessary medicines in the subjects of the Russian Federal Department of Education. Vestnik Roszdravnadzora; 2022(1):66-70. (In Russ.)]. EDN: EKFVRJ

8. Letter of the Ministry of Health of the Russian Federation dated 21.06.2023 No. 25-1/I/2-10980 «On sending a list of measures aimed at preserving the right of citizens to a set of social services in terms of medicinal provision» (In Russ.)]. Доступно по: https://clck.ru/3DkZTR. Ссылка активна на 30.09.2024.

9. Nagibin OA, Manukhina EV, Komarov IA. Statutory regulation of subsidized pharmaceutical provision in Russian Federation. I.P. Pavlov Russian Medical Biological Herald. 2019;27(4):520-529. (In Russ.)]. doi: 10.23888/PAVLOVJ2019274520-529.

10. Petrukhina IК, Yagudina RI, Veyner NV, et al. Peculiarities of administration of medications to patients with circulatory system diseases within the framework of the federal program of preferential provision of medicines. FARMAKOEKONOMIKA. Modern Pharmacoeconomics and Pharmacoepidemiology. 2021;14(3):311-323. (In Russ.)]. doi: 10.17749/2070-490.

11. Yagudina RI, Kulikov AYu, Serpik VG, et al. Pharmacoeconomics and drug provision: cardiovascular diseases. — Rostov on Don: Fenix, 2019. (In Russ.)].

12. Petrukhina IK, Yagudina RI, Egorova GA, et al. Analysis of main indicators for implementing the Essential Drug Program for population of the Samara Region. Pharmacy. 2019;68(1):33-41. (In Russ.)]. doi: 10/29296/25419218-2019-01-05.

13. Dzhuparova IA., Kharina IA. Comparative analysis of the federal and regional segments of preferent drug provision on the example of patients with type 2 diabetes in the Novosibirsk Region. Pharmacoeconomics. Theory and practice. 2023;11(2):16. (In Russ.)]. doi: 10.30809/phe.2.2023.7

14. Drapkina OM, Samorodskaia IV, Bolotova EV, Starinskaya MA. The nosological structure of years of potential life lost in the economically active age in the Russian Federation in 2016. Russian Journal of Preventive Medicine. 2019;22(1):22-28. (In Russ.)]. doi: 10.17116/profmed20192201122.

15. Federal Law of July 27, 2006 No. 152-FZ «On Personal Data» (as amended and supplemented on February 6, 2023) (In Russ.)]. Доступно по: https://ivo.garant.ru/#/document/12148567/paragraph/24880:0. Ссылка активна на 30.09.2024.

16. Procurement: official website of the Unified Information System in the Sphere of Procurement (In Russ.)]. [Online]. Available: https://zakupki.gov.ru/epz/order/extendedsearch/results.html

17. State Standard of Russia 57525–2017. National standard of the Russian Federation «Clinical and economic studies. General requirements». Official publication. Moscow: Standartinform, 2017. (In Russ.)].

18. Zaripova GR, Bakirov BA, Kudlay DA, et al. ABC/VEN-analysis of medication consumption in a multidisciplinary hospital. Klinicheskaya farmakologiya i terapiya = Clinical Pharmacology and Therapy. 2024;33(2):84-88 (In Russ.)]. doi: 10.32756/0869-5490-2024-2-84-88.

19. Federal Guidelines for the Use of Medicines (Formulary System) / Ed by AG Chuchalin, VV Yasnetsov. Moscow: Vidoks, 2016. — Issue XVII. (In Russ.)].

20. Федеральное руководство по использованию лекарственных средств (формулярная система) / Под ред. А.Г. Чучалина, А.Л. Хохлова. — М.: Видокс, 2017. — Выпуск XVIII. — 848 с. [Federal Guidelines for the Use of Medicines (Formulary System) / Ed by AG Chuchalin, AL Khokhlova. Moscow: Vidoks, 2017. Issue XVIII. (In Russ.)].

21. Pulmonology: federal guidelines for the use of drugs (formulary system) / scientific ed. AG Chuchalin, AL Khokhlov. Moscow: Vidoks, 2018. Issue 19. (In Russ.)].

22. WHO Model List of Essential Medicines. 18th list (April 2013). (In Russ.)]. Доступно по: https://clck.ru/3DkaA7. Ссылка активнана 30.09.2024.

23. The selection and use of essential medicines 2023. Web Annex A [Electronic resource] / World Health Organization. Model List of Essential Medicines. 23rd list (2023). Geneva: World Health Organization; 2023. Available from: https://clck.ru/3DkaEL. (accessed Sept. 30, 2024).